论文部分内容阅读
目的:探讨经尿道前列腺双极等离子剜除术(PKERP)治疗良性前列腺增生的临床疗效。方法:回顾性分析2012年6月~2014年1月采用PKERP治疗良性前列腺增生症(BPH)的55例患者的临床资料。对患者的手术时间、手术并发症、手术前和手术后的前列腺重量、前列腺症状评分(IPSS)、生活质量评分(QOL),最大尿流率(Qmax)等进行了比较分析。同时和同期采用经尿道等离子切除(PKRP)的50例患者进行比较。结果:所有患者均未出现电切综合征,无尿道狭窄及膀胱颈口挛缩。采用PKERP患者手术时间(107.20±24.48)min,手术后6个月时Qmax、IPSS和QOL评分等均较术前明显改善(P<0.05)。PKERP组与PKRP组在手术时间、留置尿管时间、住院天数、术后IPSS和QOL评分、Qmax等进行比较,两者均差异无统计学意义(P>0.05),但在切除前列腺组织重量方面差异有统计学意义(P<0.05)。结论:PKERP治疗BPH具有良好的疗效和安全性,可以获得更彻底的前列腺组织切除,术后效果好,是腔内前列腺切除的有效手术方式。
Objective: To investigate the clinical efficacy of transurethral prostate bipolar plasmaassay (PKERP) in the treatment of benign prostatic hyperplasia. Methods: The clinical data of 55 patients with benign prostatic hyperplasia (BPH) treated with PKERP from June 2012 to January 2014 were retrospectively analyzed. Patient’s operation time, surgical complications, preoperative and postoperative prostate weight, prostate symptom score (IPSS), quality of life score (QOL), maximum flow rate (Qmax) were compared. Simultaneous with the 50 patients who underwent transurethral plasmapheresis (PKRP) at the same time. Results: All patients did not appear power-cut syndrome, no urethral stricture and bladder neck contracture. The operation time of PKERP patients (107.20 ± 24.48) min, Qmax, IPSS and QOL scores at 6 months after operation were significantly improved compared with those before operation (P <0.05). There was no significant difference between PKERP group and PKRP group in operation time, indwelling catheter time, days of hospitalization, postoperative IPSS and QOL score, Qmax, etc. There was no significant difference between PKERP group and PKRP group (P> 0.05) The difference was statistically significant (P <0.05). Conclusion: PKERP has a good curative effect and safety for BPH, which can get a more thorough resection of prostate tissue and has a good postoperative effect. It is an effective surgical method for endoluminal resection of the prostate.